These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Immunoglobulin class (IgG, IgM) determination by dithiothreitol in sensitized kidney transplant candidates. Khodadadi L; Adib M; Pourazar A Transplant Proc; 2006 Nov; 38(9):2813-5. PubMed ID: 17112836 [TBL] [Abstract][Full Text] [Related]
5. Absence of irreversible rejection in the presence of warm anti-donor-HLA class I cytotoxic IgG antibody. Shoker A; Klassen J; Herbut B Clin Nephrol; 1997 Feb; 47(2):87-91. PubMed ID: 9049455 [TBL] [Abstract][Full Text] [Related]
6. Flow cytometry-detected IgG is not a contraindication to renal transplantation: IgM may be beneficial to outcome. Kerman RH; Susskind B; Buyse I; Pryzbylowski P; Ruth J; Warnell S; Gruber SA; Katz S; Van Buren CT; Kahan BD Transplantation; 1999 Dec; 68(12):1855-8. PubMed ID: 10628764 [TBL] [Abstract][Full Text] [Related]
7. IgM antibodies in renal transplantation. McCalmon RT; Tardif GN; Sheehan MA; Fitting K; Kortz W; Kam I Clin Transplant; 1997 Dec; 11(6):558-64. PubMed ID: 9408684 [TBL] [Abstract][Full Text] [Related]
8. Is positive flow cytometric cross-match a risk factor for early cadaveric kidney graft dysfunction? Piatosa B; Rubik J; Grenda R Transplant Proc; 2006; 38(1):53-5. PubMed ID: 16504662 [TBL] [Abstract][Full Text] [Related]
10. The role of flow cytometry-detected IgG and IgM anti-donor antibodies in cardiac allograft recipients. Przybylowski P; Balogna M; Radovancevic B; Frazier OH; Susskind B; Van Buren C; Katz S; Kahan BD; Kerman R Transplantation; 1999 Jan; 67(2):258-62. PubMed ID: 10075590 [TBL] [Abstract][Full Text] [Related]
11. B cell positive cross-match not due to anti-HLA Class I antibodies and first kidney graft outcome. Praticò-Barbato L; Conca R; Magistroni P; Leonardi G; Oda A; Rosati F; Leone E; Tacconella M; Roggero S; Segoloni GP; Amoroso A Transpl Immunol; 2008 Jul; 19(3-4):238-43. PubMed ID: 18675725 [TBL] [Abstract][Full Text] [Related]
12. Clinical significance of a positive flow crossmatch on the outcomes of cadaveric renal transplants. Ilham MA; Winkler S; Coates E; Rizzello A; Rees TJ; Asderakis A Transplant Proc; 2008; 40(6):1839-43. PubMed ID: 18675065 [TBL] [Abstract][Full Text] [Related]
13. Clinical relevance of preformed IgG and IgM antibodies against donor endothelial progenitor cells in recipients of living donor kidney grafts. Daniel V; Sadeghi M; Suesal C; Scherer S; Tran H; Gombos P; Trojan K; Morath C; Opelz G Clin Transplant; 2016 Feb; 30(2):124-30. PubMed ID: 26537026 [TBL] [Abstract][Full Text] [Related]
14. Hyperacute rejection of living related kidney grafts caused by endothelial cell-specific antibodies: case reports. Grandtnerová B; Mäcková N; Hovoricová B; Jahnová E Transplant Proc; 2008 Sep; 40(7):2422-4. PubMed ID: 18790254 [TBL] [Abstract][Full Text] [Related]
15. The crossmatch in renal transplantation. Evaluation of flow cytometry as a replacement for standard cytotoxicity. Scornik JC; Brunson ME; Schaub B; Howard RJ; Pfaff WW Transplantation; 1994 Feb; 57(4):621-5. PubMed ID: 8116050 [TBL] [Abstract][Full Text] [Related]
16. Subtypes of immunoglobulin (Ig)-G antibodies against donor class II HLA and cross-match results in three kidney transplant candidates. Lobashevsky A; Rosner K; Goggins W; Higgins N Transpl Immunol; 2010 May; 23(1-2):81-5. PubMed ID: 20304065 [TBL] [Abstract][Full Text] [Related]
17. [Can one graft with a positive cross-match?]. Alamartine E; Acquart S; Absi L; Diab N; de Filippis JP; Le Petit JC; Berthoux F Nephrologie; 1997; 18(5):175-80. PubMed ID: 9424594 [TBL] [Abstract][Full Text] [Related]